Top compounds associated with response to CLCN4


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Irinotecan CCLE pan-cancer AAC -0.16 0.003
mRNA FH535 GDSC1000 pan-cancer AAC -0.099 0.003
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.11 0.004
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.005
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.005
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC 0.1 0.005
Download CSV